{"disease":{"id":"axillary-hyperhidrosis","name":"axillary hyperhidrosis"},"drugs":{"marketed":[{"drug_id":"onabotulinumtoxina","indication_name":"Severe Axillary Hyperhidrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Botox","generic_name":"ONABOTULINUMTOXINA","company_name":"Allergan","drug_phase":"marketed","molecular_target":"SNAP-25","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":60,"revenue":"5300","mechanism":"BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03658616","title":"Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":518,"lead_sponsor_name":"Dr. August Wolff GmbH & Co. KG Arzneimittel","has_results":false},{"nct_id":"NCT03948646","title":"Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT03836287","title":"Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT03627468","title":"A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT04599907","title":"Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Candesant Biomedical, Inc.","has_results":true},{"nct_id":"NCT04546438","title":"Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Region Östergötland","has_results":false},{"nct_id":"NCT07094009","title":"Comparison of the Clinical Efficacy and Adverse Reactions of Different Needling Patterns of High-frequency Microneedles in the Treatment of Axillary Odor","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT05863104","title":"Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Dr. August Wolff GmbH & Co. KG Arzneimittel","has_results":false},{"nct_id":"NCT03054480","title":"Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Mae Fah Luang University Hospital","has_results":false},{"nct_id":"NCT03785587","title":"A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT02823340","title":"Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT03320096","title":"Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Ulthera, Inc","has_results":true}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}